Cardiff Oncology, Inc. (CRDF)
0.9073
-0.02
(-2.23%)
USD |
NASDAQ |
Oct 23, 16:00
0.9006
-0.01
(-0.74%)
After-Hours: 20:00
Cardiff Oncology Price : 0.9073 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 0.92 | 0.94 | 0.885 | 0.9073 | 174708.0 |
| Oct 22, 2026 | 0.93 | 0.9738 | 0.91 | 0.928 | 228677.0 |
| Oct 21, 2026 | 0.9472 | 0.97 | 0.9219 | 0.939 | 436773.0 |
| Oct 20, 2026 | 0.9062 | 0.98 | 0.88 | 0.9315 | 595471.0 |
| Oct 19, 2026 | 0.92 | 0.9292 | 0.8829 | 0.8857 | 425667.0 |
| Oct 16, 2026 | 0.98 | 0.9949 | 0.89 | 0.9011 | 515913.0 |
| Oct 15, 2026 | 0.95 | 1.00 | 0.9496 | 0.971 | 454063.0 |
| Oct 14, 2026 | 1.06 | 1.06 | 0.9604 | 0.9734 | 413058.0 |
| Oct 13, 2026 | 1.04 | 1.045 | 1.00 | 1.01 | 504923.0 |
| Oct 12, 2026 | 1.08 | 1.08 | 1.04 | 1.04 | 378935.0 |
| Oct 09, 2026 | 1.06 | 1.11 | 1.06 | 1.08 | 298116.0 |
| Oct 08, 2026 | 1.07 | 1.08 | 1.05 | 1.06 | 540980.0 |
| Oct 07, 2026 | 1.07 | 1.13 | 1.07 | 1.09 | 457834.0 |
| Oct 06, 2026 | 1.15 | 1.159 | 1.06 | 1.07 | 384166.0 |
| Oct 05, 2026 | 1.10 | 1.15 | 1.09 | 1.14 | 451951.0 |
| Oct 02, 2026 | 1.21 | 1.21 | 1.11 | 1.12 | 628343.0 |
| Oct 01, 2026 | 1.22 | 1.22 | 1.16 | 1.18 | 298499.0 |
| Sep 30, 2026 | 1.17 | 1.245 | 1.17 | 1.21 | 564676.0 |
| Sep 29, 2026 | 1.19 | 1.24 | 1.16 | 1.17 | 352970.0 |
| Sep 28, 2026 | 1.23 | 1.23 | 1.19 | 1.20 | 377394.0 |
| Sep 25, 2026 | 1.30 | 1.30 | 1.23 | 1.24 | 563363.0 |
| Sep 24, 2026 | 1.30 | 1.32 | 1.245 | 1.28 | 596494.0 |
| Sep 23, 2026 | 1.32 | 1.34 | 1.28 | 1.31 | 590222.0 |
| Sep 22, 2026 | 1.37 | 1.385 | 1.33 | 1.33 | 518455.0 |
| Sep 21, 2026 | 1.39 | 1.41 | 1.36 | 1.37 | 476013.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| PS Ratio | 121.24 |
| Price to Book Value | 2.342 |
| Earnings Yield | -65.09% |
| Market Cap | 62.15M |